Cargando…
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
Omicron variant is circulating in the presence of a globally acquired immunity unlike the ancestral SARS-CoV-2 isolate. Herein, we investigated the normalized viral load dynamics and viral culture status in 44 fully vaccinated healthcare workers (HCWs) infected with the Omicron BA.1 variant. Viral l...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621261/ https://www.ncbi.nlm.nih.gov/pubmed/36098494 http://dx.doi.org/10.1080/22221751.2022.2122578 |
_version_ | 1784821501345660928 |
---|---|
author | Saade, Carla Brengel-Pesce, Karen Gaymard, Alexandre Trabaud, Mary-Anne Destras, Gregory Oriol, Guy Cheynet, Valérie Debombourg, Marion Mokdad, Bouchra Billaud, Geneviève Oblette, Antoine Créhalet, Hervé Giannoli, Jean-Marc Garrigou, Christine Generenaz, Laurence Compagnon, Christelle Boibieux, André Lina, Bruno Morfin, Florence Pozzetto, Bruno Josset, Laurence Touillet-Assant, Sophie Bal, Antonin |
author_facet | Saade, Carla Brengel-Pesce, Karen Gaymard, Alexandre Trabaud, Mary-Anne Destras, Gregory Oriol, Guy Cheynet, Valérie Debombourg, Marion Mokdad, Bouchra Billaud, Geneviève Oblette, Antoine Créhalet, Hervé Giannoli, Jean-Marc Garrigou, Christine Generenaz, Laurence Compagnon, Christelle Boibieux, André Lina, Bruno Morfin, Florence Pozzetto, Bruno Josset, Laurence Touillet-Assant, Sophie Bal, Antonin |
author_sort | Saade, Carla |
collection | PubMed |
description | Omicron variant is circulating in the presence of a globally acquired immunity unlike the ancestral SARS-CoV-2 isolate. Herein, we investigated the normalized viral load dynamics and viral culture status in 44 fully vaccinated healthcare workers (HCWs) infected with the Omicron BA.1 variant. Viral load dynamics of 38 unvaccinated HCWs infected with the 20A variant during the first pandemic wave was also studied. We then explored the impact of Omicron infection on pre-existing immunity assessing anti-RBD IgG levels, neutralizing antibody titres against 19A, Delta and Omicron isolates, as well as IFN-γ release following cell stimulation with SARS-CoV-2 peptides. We reported that two weeks after diagnosis a greater proportion of HCWs infected with 20A (78.9%, 15/19) than with Omicron BA.1 (44.7%, 17/38; p = 0.02) were still positive by RT-qPCR. We found that Omicron breakthrough infections led to an overall enhancement of vaccine-induced humoral and cellular immunity as soon as a median [interquartile range] of 8 [7–9] days post symptom onset. Among samples with similar high viral loads, non-culturable samples exhibited higher neutralizing antibody titres and anti-RBD IgG levels than culturable samples. Additionally, Omicron infection led to an enhancement of antibodies neutralization capacity against other SARS-CoV-2 isolates. Taken together, the results suggest that Omicron BA.1 vaccine breakthrough infection is associated with a faster viral clearance than that of the ancestral SARS-CoV-2, in addition this new variant leads to a rapid enhancement of the humoral response against multiple SARS-CoV-2 variants, and of the cellular response. |
format | Online Article Text |
id | pubmed-9621261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-96212612022-11-01 Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections Saade, Carla Brengel-Pesce, Karen Gaymard, Alexandre Trabaud, Mary-Anne Destras, Gregory Oriol, Guy Cheynet, Valérie Debombourg, Marion Mokdad, Bouchra Billaud, Geneviève Oblette, Antoine Créhalet, Hervé Giannoli, Jean-Marc Garrigou, Christine Generenaz, Laurence Compagnon, Christelle Boibieux, André Lina, Bruno Morfin, Florence Pozzetto, Bruno Josset, Laurence Touillet-Assant, Sophie Bal, Antonin Emerg Microbes Infect Coronaviruses Omicron variant is circulating in the presence of a globally acquired immunity unlike the ancestral SARS-CoV-2 isolate. Herein, we investigated the normalized viral load dynamics and viral culture status in 44 fully vaccinated healthcare workers (HCWs) infected with the Omicron BA.1 variant. Viral load dynamics of 38 unvaccinated HCWs infected with the 20A variant during the first pandemic wave was also studied. We then explored the impact of Omicron infection on pre-existing immunity assessing anti-RBD IgG levels, neutralizing antibody titres against 19A, Delta and Omicron isolates, as well as IFN-γ release following cell stimulation with SARS-CoV-2 peptides. We reported that two weeks after diagnosis a greater proportion of HCWs infected with 20A (78.9%, 15/19) than with Omicron BA.1 (44.7%, 17/38; p = 0.02) were still positive by RT-qPCR. We found that Omicron breakthrough infections led to an overall enhancement of vaccine-induced humoral and cellular immunity as soon as a median [interquartile range] of 8 [7–9] days post symptom onset. Among samples with similar high viral loads, non-culturable samples exhibited higher neutralizing antibody titres and anti-RBD IgG levels than culturable samples. Additionally, Omicron infection led to an enhancement of antibodies neutralization capacity against other SARS-CoV-2 isolates. Taken together, the results suggest that Omicron BA.1 vaccine breakthrough infection is associated with a faster viral clearance than that of the ancestral SARS-CoV-2, in addition this new variant leads to a rapid enhancement of the humoral response against multiple SARS-CoV-2 variants, and of the cellular response. Taylor & Francis 2022-10-26 /pmc/articles/PMC9621261/ /pubmed/36098494 http://dx.doi.org/10.1080/22221751.2022.2122578 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Coronaviruses Saade, Carla Brengel-Pesce, Karen Gaymard, Alexandre Trabaud, Mary-Anne Destras, Gregory Oriol, Guy Cheynet, Valérie Debombourg, Marion Mokdad, Bouchra Billaud, Geneviève Oblette, Antoine Créhalet, Hervé Giannoli, Jean-Marc Garrigou, Christine Generenaz, Laurence Compagnon, Christelle Boibieux, André Lina, Bruno Morfin, Florence Pozzetto, Bruno Josset, Laurence Touillet-Assant, Sophie Bal, Antonin Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections |
title | Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections |
title_full | Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections |
title_fullStr | Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections |
title_full_unstemmed | Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections |
title_short | Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections |
title_sort | dynamics of viral shedding during ancestral or omicron ba.1 sars-cov-2 infection and enhancement of pre-existing immunity during breakthrough infections |
topic | Coronaviruses |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621261/ https://www.ncbi.nlm.nih.gov/pubmed/36098494 http://dx.doi.org/10.1080/22221751.2022.2122578 |
work_keys_str_mv | AT saadecarla dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT brengelpescekaren dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT gaymardalexandre dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT trabaudmaryanne dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT destrasgregory dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT oriolguy dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT cheynetvalerie dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT debombourgmarion dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT mokdadbouchra dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT billaudgenevieve dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT obletteantoine dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT crehaletherve dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT giannolijeanmarc dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT garrigouchristine dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT generenazlaurence dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT compagnonchristelle dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT boibieuxandre dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT linabruno dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT morfinflorence dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT pozzettobruno dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT jossetlaurence dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT touilletassantsophie dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections AT balantonin dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections |